219A: Heartseed Inc. - Summary | Jitta

Heartseed Inc.

TYO:219A

Price
¥1,783.00
Loss Chance
54.1%
2.10JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
111 / 184
2,483 / 3,513
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (28)
Recent Business Performance (58)
Financial Strength (23)
Return to Shareholders (0)
Competitive Advantage (26)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Key Stats
Jitta Score
Jitta Line
2.10
> 1,000%
2.16
172.04%
4.36
368.05%
Biotechnology
3.32
100.00%
2.52
100.00%
4.79
100.00%
COMPANY DESCRIPTION
Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. In addition, the company offers differentiation induction, mass culture, purification, and myocardial globule production technology. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.